Literature DB >> 17579369

Restless legs syndrome in Parkinson's disease.

Juan C Gómez-Esteban1, Juan J Zarranz, Beatriz Tijero, Fernando Velasco, Joseba Barcena, Idoia Rouco, Elena Lezcano, María C Lachen, Amaia Jauregui, Amaia Ugarte.   

Abstract

The present study explores the frequency of RLS in PD and focuses on the clinical differences between patients with and without restless legs syndrome (RLS). A cross-sectional study was designed, comprising 114 patients diagnosed with PD. Those patients positive for RLS were assessed for intensity of the syndrome (IRLS). We compared the clinical characteristics of the patients with and without RLS, using specific scales: Unified Parkinson's Disease Rating Scale (UPDRS I-IV), quality of life (Parkinson's Disease Questionnaire, PDQ 39), sleep symptoms (Parkinson's Disease Sleep Scale, PDSS), and diurnal hypersomnia (Epworth Sleepiness Scale). Twenty-five patients (21.9%) out of a total of 114 subjects diagnosed with PD met the RLS diagnostic criteria. RLS was more frequent in women (68%). The patients with RLS showed poorer scores on the PDSS (PD-RLS+: 102.4 +/- 15.1 vs PD-RLS-: 113.2 +/- 16.4) (P = 0.005) and in the bodily discomfort dimension of the PDQ-39 (PD-RLS+ 6.1 +/- 3.4 vs PD-RLS- 3.8 +/- 2.6) (P = 0.002). Analysis of the subscales of the PDSS showed significant differences (P < 0.001) between both groups of patients in items 4 and 10, and to a lesser degree in items 5 (P = 0.01) and 11 (P = 0.02) There was no increased incidence of diurnal hypersomnia in the group of patients with RLS. There were no differences in the rest of the variables. RLS is frequent in patients with PD, though this condition doesn't apparently affect quality of life or lead to an increased presence of diurnal hypersomnia. It would be advisable to validate the diagnostic criteria of RLS in this specific group of patients. 2007 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579369     DOI: 10.1002/mds.21624

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  30 in total

1.  A review of the use of zonisamide in Parkinson's disease.

Authors:  Pedro Emilio Bermejo; Buenaventura Anciones
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

2.  Sleep disorders and daytime sleepiness in Parkinson's disease.

Authors:  Renee Monderer; Michael Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

Review 3.  An update on the pathophysiology and genetics of restless legs syndrome.

Authors:  Lynn Marie Trotti; Srinivas Bhadriraju; David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

4.  Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease.

Authors:  Vladana Spica; Tatjana Pekmezović; Marina Svetel; Vladimir S Kostić
Journal:  J Neurol       Date:  2012-07-22       Impact factor: 4.849

5.  Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome.

Authors:  Charles H Adler; Joseph G Hentz; Holly A Shill; Marwan N Sabbagh; Erika Driver-Dunckley; Virgilio G H Evidente; Sandra A Jacobson; Thomas G Beach; Bradley Boeve; John N Caviness
Journal:  Parkinsonism Relat Disord       Date:  2011-04-08       Impact factor: 4.891

6.  A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson's disease.

Authors:  Stefano Calzetti; Monica Angelini; Anna Negrotti; Elena Marchesi; Matteo Goldoni
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

7.  Absence of co-morbidity of Parkinson disease and restless legs syndrome: a case-control study in patients attending a movement disorders clinic.

Authors:  Stefano Calzetti; Anna Negrotti; Giuseppe Bonavina; Monica Angelini; Elena Marchesi
Journal:  Neurol Sci       Date:  2009-03-10       Impact factor: 3.307

8.  Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep.

Authors:  Y-Y Lai; K-C Hsieh; D Nguyen; J Peever; J M Siegel
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

9.  Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.

Authors:  R Savica; B R Grossardt; J M Carlin; M Icen; J H Bower; J E Ahlskog; D M Maraganore; D P Steensma; W A Rocca
Journal:  Neurology       Date:  2009-10-27       Impact factor: 9.910

Review 10.  Economic and human costs of restless legs syndrome.

Authors:  Thomas Reinhold; Falk Müller-Riemenschneider; Stefan N Willich; Bernd Brüggenjürgen
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.